Table 13 Final IOP outcome and visual acuity according to the use of anti-metabolites (mitomycin C (MMC))
Final IOP outcome | Visual acuity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complete success | Partial success | Failure | Improvement | Unchanged | Worsening | |||||||
n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | |
MMC | 10 (50) | 18–82% | 3 (15) | 0–41% | 7 (48) | 17–79% | 12 (60) | 28–92% | 5 (25) | 0–53% | 3 (15) | 0–41% |
No MMC | 3 (43) | 0–97% | 0 (0) | – | 4 (57) | 3–100% | 3 (43) | 0–97% | 0 (0) | – | 4 (57) | 3–100% |